Amoxicillin/Clavulanic Acid for the Treatment of Odontogenic Infections: A Randomised Study Comparing Efficacy and Tolerability versus Clindamycin

Archiel Launch Tancawan, Maria Noemi Pato, Khamiza Zainol Abidin, A S Mohd Asari, Tran Xuan Thong, Puja Kochhar, Chandra Muganurmath, Monique Twynholm, Keith Barker, Archiel Launch Tancawan, Maria Noemi Pato, Khamiza Zainol Abidin, A S Mohd Asari, Tran Xuan Thong, Puja Kochhar, Chandra Muganurmath, Monique Twynholm, Keith Barker

Abstract

Background. Treatment of odontogenic infections includes surgical drainage and adjunctive antibiotics. This study was designed to generate efficacy and safety data to support twice daily dosing of amoxicillin/clavulanic acid compared to clindamycin in odontogenic infections. Methods. This was a phase IV, randomised, observer blind study; 472 subjects were randomised to receive amoxicillin/clavulanic acid (875 mg/125 mg BID, n = 235) or clindamycin (150 mg QID, n = 237) for 5 or 7 days based on clinical response. The primary endpoint was percentage of subjects achieving clinical success (composite measure of pain, swelling, fever, and additional antimicrobial therapy required) at the end of treatment. Results. The upper limit of two-sided 95% confidence interval for the treatment difference between the study arms (7.7%) was within protocol specified noninferiority margin of 10%, thus demonstrating noninferiority of amoxicillin/clavulanic acid to clindamycin. Secondary efficacy results showed a higher clinical success rate at Day 5 in the amoxicillin/clavulanic acid arm. Most adverse events (raised liver enzymes, diarrhoea, and headache) were similar across both arms and were of mild to moderate intensity. Conclusion. Amoxicillin/clavulanic acid was comparable to clindamycin in achieving clinical success (88.2% versus 89.7%) in acute odontogenic infections and the safety profile was consistent with the known side effects of both drugs. Trial Registration. This trial is registered with Clinicaltrials.gov identifier: NCT02141217.

Figures

Figure 1
Figure 1
Study schema. Note: the study had a 1-day screening period (Day 1 to Day 0) during which eligibility was assessed and laboratory tests were performed. Randomisation occurred within 24 hours of screening at baseline (Day 0). Further visits (Day 2, Day 5, and Day 7) were calculated from the baseline/randomisation visit (Day 0).
Figure 2
Figure 2
Scatter plot of LFT with respect to baseline and end of study by treatment. Normalised value = laboratory value/upper limit of normal reference range of the respective local laboratory.

References

    1. Dar-Odeh N. S., Abu-Hammad O., Al-Omiri M. K., Khraisat A. S., Shehabi A. A. Antibiotic prescribing practices by dentists: a review. Therapeutics and Clinical Risk Management. 2010;6:301–306. doi: 10.2147/tcrm.s9736.
    1. López-Píriz R., Aguilar L., Giménez M. J. Management of odontogenic infection of pulpal and periodontal origin. Medicina Oral, Patología Oral y Cirugía Bucal. 2007;12(2):E154–E159.
    1. Robertson D., Smith A. J. The microbiology of the acute dental abscess. Journal of Medical Microbiology. 2009;58(2):155–162. doi: 10.1099/jmm.0.003517-0.
    1. Martínez A. B., Urízar J. M. A., Fenoll A. B., et al. Consensus statement on antimicrobial treatment of odontogenic bacterial infections. Medicina Oral, Patologia Oral y Cirugia Bucal. 2004;9(5):363–376.
    1. Brook I., Frazier E. H., Gher M. E. Aerobic and anaerobic microbiology of periapical abscess. Oral Microbiology and Immunology. 1991;6(2):123–125. doi: 10.1111/j.1399-302x.1991.tb00464.x.
    1. Brook I., Lewis M. A. O., Sándor G. K. B., Jeffcoat M., Samaranayake L. P., Rojas J. V. Clindamycin in dentistry: more than just effective prophylaxis for endocarditis? Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology. 2005;100(5):550–558. doi: 10.1016/j.tripleo.2005.02.086.
    1. Walker C., Gordon J. The effect of clindamycin on the microbiota associated with refractory periodontitis. Journal of Periodontology. 1990;61(11):692–698. doi: 10.1902/jop.1990.61.11.692.
    1. Gilmore W. C., Jacobus N. V., Gorbach S. L., Doku H. C., Tally F. P. A prospective double-blind evaluation of penicillin versus clindamycin in the treatment of odontogenic infections. Journal of Oral and Maxillofacial Surgery. 1988;46(12):1065–1070. doi: 10.1016/0278-2391(88)90452-1.
    1. Von Konow L., Kondell P. A., Nord C. E., Heimdahl A. Clindamycin versus phenoxymethylpenicillin in the treatment of acute orofacial infections. European Journal of Clinical Microbiology and Infectious Diseases. 1992;11(12):1129–1135. doi: 10.1007/bf01961131.
    1. Mangundjaja S., Hardjawinata K. Clindamycin versus ampicillin in the treatment of odontogenic infections. Clinical Therapeutics. 1990;12(3):242–249.
    1. Gordon J., Walker C., Hovliaras C., Socransky S. Efficacy of clindamycin hydrochloride in refractory periodontitis: 24-month results. Journal of Periodontology. 1990;61(11):686–691. doi: 10.1902/jop.1990.61.11.686.
    1. Ellison S. J. An outcome audit of three day antimicrobial prescribing for the acute dentoalveolar abscess. British Dental Journal. 2011;211(12):591–594. doi: 10.1038/sj.bdj.2011.1051.
    1. Al-Selivany B. J., Al-Derzi N. A., Agha S. Y. Dental infections: clinical and microbiological evaluation of responsiveness to twice daily amoxicillin-clavulanic acid (amoxiclave) Jordan Medical Journal. 2010;44(3):305–312.
    1. Adriaenssen C. F. Comparison of the efficacy, safety and tolerability of azithromycin and co-amoxiclav in the treatment of acute periapical abscesses. Journal of International Medical Research. 1998;26(5):257–265.
    1. Sulejmanagić N., Sulejmanagić H., Ljutović Z., Salihagić D., Sijercić M. Combined application of amoxicillin and clavulanic acid after oral surgical interventions. Bosnian Journal of Basic Medical Sciences. 2005;5(1):61–68.
    1. AUGMENTIN 875/125MG. Amoxicillin/clavulanic acid. Product Information, 2013.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する